This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alexander Zemtsov, MD, MS; Lisa Dixon, MSc

Arch Dermatol. 1993;129(2):215-218.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Magnetic resonance imaging (MRI), a technique that has had a truly revolutionary impact on many areas of clinical medicine,¹ is starting to be appreciated by the dermatologic community. In this issue of the ARCHIVES, Truhan and Filipek² describe central nervous system MRI findings in patients with neurofibromatosis, tuberosclerosis, and Sturge-Weber syndrome. This is a comprehensive and well-written review on the subject. However, as the authors point out, in the majority of neurocutaneous syndromes, "consistent characteristic CNS findings by MRI have not yet been described."² For example, central nervous system MRI findings in patients with hypomelanosis of Ito are still poorly characterized and are inconsistent.^3,4 The use of MRI surface coils permits direct evaluation and characterization of dermatologic conditions by MR techniques. The evaluation of cutaneous diseases by MR techniques can be subdivided into three areas: (1) the evaluation of skin tumors by MRI using standard commercially . . . [Full Text PDF of this Article]

Author Affiliations
Departments of Dermatology and Biochemistry; Department of Radiology Texas Tech University School of Medicine 3601 Fourth St Lubbock, TX 79430

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?